The visual symptoms arise when TRPM1 autoantibodies enter ON-BCs and block the function of TRPM1, thus detection of TRPM1 autoantibodies in patient serum is a key criterion in diagnosing MAR. Here, TRPM1 is linked to myelodysplastic syndrome associated with isolated del(5q).